1072833-77-2

MLN2238 CS-1976 IxazoMib Ixazomib-d7 ixazomib(MLN2238) MLN2238(iaxzomib) MLN2238(Ixazomib) Ixazomib (MLN-9708) Ixazomib (10mM in DMSO) MLN2238;MLN 2238;MLN-2238 IXAZOMIB;MLN 2238;MLN-2238 1-(2-(2,5-dichlorobenzamido)acetamido)- 3-methylbutylboronic acid (R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid (R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbuyl)boronic acid (1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid Boronic acid, B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]- Ixazomib-13C2,15NQ: What is Ixazomib-13C2,15N Q: What is the CAS Number of Ixazomib-13C2,15N B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid Ixazomib (MLN2238) Ixazomib, 98%, a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM)